(GLOB) Globant - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 1.733m USD | Total Return: -60.5% in 12m
Avg Turnover: 68.3M
EPS Trend: 1.0%
Qual. Beats: 2
Rev. Trend: 91.7%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Garp
Globant S.A. (GLOB) is a Luxembourg-based technology services firm specializing in digital transformation and software development. The company operates through a Studio model, which organizes specialized teams to deliver artificial intelligence, experiential marketing, and enterprise operations across diverse sectors including finance, healthcare, and media.
The business model relies on a mix of project-based consulting and subscription-based service delivery, such as its AI Pods. As an Application Software provider, Globant differentiates itself by integrating proprietary platforms like GeneXus and StarMeUp to automate software evolution and enhance employee engagement for its global client base.
The IT services sector is currently experiencing a structural shift as enterprises transition from traditional cloud migration toward agentic AI workflows and industrial-scale model fine-tuning. For a deeper look at how these technical shifts impact valuation, consider exploring the data on ValueRay.
Recent strategic expansions include the launch of specialized AI Hubs and an Agents Hub designed to coordinate autonomous workflows across physical and digital environments. These initiatives aim to streamline the software development lifecycle while providing industry-specific solutions for complex sectors like life sciences and automotive.
- Enterprise digital transformation spending drives core revenue growth across global markets
- AI-powered software development lifecycle integration expands operating margins and efficiency
- Geographic diversification reduces exposure to specific regional macroeconomic or political volatility
- High-growth industry vertical expansion mitigates sector-specific client budget constraints
- Strategic acquisitions and studio model scaling influence long-term capital allocation efficiency
| Net Income: 109.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.86 > 1.0 |
| NWC/Revenue: 16.91% < 20% (prev 12.86%; Δ 4.05% < -1%) |
| CFO/TA 0.10 > 3% & CFO 319.2m > Net Income 109.3m |
| Net Debt (363.0m) to EBITDA (335.9m): 1.08 < 3 |
| Current Ratio: 1.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.4m) vs 12m ago -4.05% < -2% |
| Gross Margin: 32.65% > 18% (prev 0.36%; Δ 3.23k% > 0.5%) |
| Asset Turnover: 75.34% > 50% (prev 75.77%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 4.74 > 6 (EBITDA TTM 335.9m / Interest Expense TTM 37.3m) |
| A: 0.13 (Total Current Assets 921.3m - Total Current Liabilities 506.9m) / Total Assets 3.27b |
| B: 0.31 (Retained Earnings 1.00b / Total Assets 3.27b) |
| C: 0.05 (EBIT TTM 176.6m / Avg Total Assets 3.25b) |
| D: 0.89 (Book Value of Equity 954.0m / Total Liabilities 1.07b) |
| Altman-Z'' = 3.13 = A |
| DSRI: 0.97 (Receivables 682.1m/706.2m, Revenue 2.45b/2.46b) |
| GMI: 1.11 (GM 32.65% / 36.12%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.00 (Revenue 2.45b / 2.46b) |
| TATA: -0.06 (NI 109.3m - CFO 319.2m) / TA 3.27b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 40.13 with a total of 1,043,132 shares traded.
Over the past week, the price has changed by +3.14%,
over one month by -6.33%,
over three months by -5.20% and
over the past year by -60.52%.
Globant has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy GLOB.
- StrongBuy: 8
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 62.5 | 55.7% |
P/E Trailing = 16.313
P/E Forward = 6.402
P/S = 0.707
P/B = 0.8165
P/EG = 1.0492
Revenue TTM = 2.45b USD
EBIT TTM = 176.6m USD
EBITDA TTM = 335.9m USD
Long Term Debt = 342.3m USD (from longTermDebt, last quarter)
Short Term Debt = 48.0m USD (from shortTermDebt, last quarter)
Debt = 563.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 100.9m
Net Debt = 363.0m USD (calculated: Debt 563.6m - CCE 200.5m)
Enterprise Value = 2.10b USD (1.73b + Debt 563.6m - CCE 200.5m)
Interest Coverage Ratio = 4.74 (Ebit TTM 176.6m / Interest Expense TTM 37.3m)
EV/FCF = 6.92x (Enterprise Value 2.10b / FCF TTM 303.0m)
FCF Yield = 14.46% (FCF TTM 303.0m / Enterprise Value 2.10b)
FCF Margin = 12.36% (FCF TTM 303.0m / Revenue TTM 2.45b)
Net Margin = 4.46% (Net Income TTM 109.3m / Revenue TTM 2.45b)
Gross Margin = 32.65% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 30.13% (prev 34.89%)
Tobins Q-Ratio = 0.64 (Enterprise Value 2.10b / Total Assets 3.27b)
Interest Expense / Debt = 6.61% (Interest Expense 37.3m / Debt 563.6m)
Taxrate = 23.49% (11.9m / 50.7m)
NOPAT = 135.1m (EBIT 176.6m * (1 - 23.49%))
Current Ratio = 1.82 (Total Current Assets 921.3m / Total Current Liabilities 506.9m)
Debt / Equity = 0.27 (Debt 563.6m / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 1.08 (Net Debt 363.0m / EBITDA 335.9m)
Debt / FCF = 1.20 (Net Debt 363.0m / FCF TTM 303.0m)
Total Stockholder Equity = 2.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.36% (Net Income 109.3m / Total Assets 3.27b)
RoE = 5.14% (Net Income TTM 109.3m / Total Stockholder Equity 2.13b)
RoCE = 7.15% (EBIT 176.6m / Capital Employed (Equity 2.13b + L.T.Debt 342.3m))
RoIC = 4.85% (NOPAT 135.1m / Invested Capital 2.79b)
WACC = 9.42% (E(1.73b)/V(2.30b) * Re(10.84%) + D(563.6m)/V(2.30b) * Rd(6.61%) * (1-Tc(0.23)))
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 21.08 | Cagr: -1.02%
[DCF] Terminal Value 74.58% ; FCFF base≈265.0m ; Y1≈303.7m ; Y5≈447.0m
[DCF] Fair Price = 122.7 (EV 5.66b - Net Debt 363.0m = Equity 5.30b / Shares 43.2m; r=9.42% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 1.01 | EPS CAGR: 0.10% | SUE: 1.72 | # QB: 2
Revenue Correlation: 91.66 | Revenue CAGR: 9.60% | SUE: 1.11 | # QB: 2
EPS current Quarter (2026-06-30): EPS=1.51 | Chg30d=-2.83% | Revisions=-53% | Analysts=15
EPS next Quarter (2026-09-30): EPS=1.61 | Chg30d=+0.43% | Revisions=+12% | Analysts=15
EPS current Year (2026-12-31): EPS=6.24 | Chg30d=-0.08% | Revisions=+7% | GrowthEPS=+1.6% | GrowthRev=+1.1%
EPS next Year (2027-12-31): EPS=6.63 | Chg30d=-0.56% | Revisions=-12% | GrowthEPS=+6.3% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: -53%